Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 2Breast 2

Conditions

Ovarian Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Breast Neoplasms 1

Interventions

pembrolizumab 1270Specimen Handling 870Carboplatin 831Magnetic Resonance Spectroscopy 808Cyclophosphamide 802Cisplatin 728Nivolumab 658Paclitaxel 631Radiotherapy 573Gemcitabine 572Biopsy 529Bevacizumab 475Dexamethasone 440fludarabine 407Docetaxel 378venetoclax 370Oxaliplatin 365Capecitabine 356Fluorouracil 354atezolizumab 341durvalumab 334Rituximab 332Doxorubicin 316Radiosurgery 309Pemetrexed 305Drug Therapy 302Ipilimumab 294Standard of Care 293Etoposide 285Radiation 279

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Ovariectomy × 1 year × Clear all
NCT04251052 2026-03-27

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

NRG Oncology

Phase NA Recruiting
1,956 enrolled
Gynecologic

Ovarian Neoplasms

NCT00066690 2026-02-06

SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed
3,066 enrolled 15 charts
Breast

Breast Neoplasms

NCT02760849 2026-01-07

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

M.D. Anderson Cancer Center

Phase NA Active not recruiting
374 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡